How Semax Was Derived From an ACTH Peptide Fragment

How Semax Was Derived From an ACTH Peptide Fragment

How Semax was derived from an ACTH peptide fragment is explained by its two-part sequence design: researchers retained ACTH residues 4 through 7, Met-Glu-His-Phe, and attached Pro-Gly-Pro to the C terminus, producing the seven-residue peptide Met-Glu-His-Phe-Pro-Gly-Pro. Semax therefore preserves a short ACTH-derived N-terminal segment while replacing the remainder of the ACTH(4-10) sequence with a PGP extension intended to improve the fragment’s resistance to enzymatic degradation.

The derivation of Semax provides a useful example of peptide-engineering logic within Semax Research. Rather than copying the complete endocrine hormone, the design selected a restricted ACTH fragment and altered its C-terminal region to create a distinct synthetic regulatory peptide.

Research-use notice: InStrips products are offered for research and analytical use only. They are not intended to diagnose, treat, cure, or prevent any disease, injury, deficiency, absorption disorder, digestive condition, or medical condition.

The Starting Molecule Was ACTH

Adrenocorticotropic hormone is a 39-amino-acid peptide generated biologically from proopiomelanocortin.

Its sequence can be divided conceptually into smaller regions for structure-activity studies.

Researchers have investigated numerous ACTH fragments to determine which molecular features contribute to different biological responses.

Fragment Research Asks What a Smaller Sequence Can Retain

A full peptide hormone may contain structural determinants for several activities.

By testing fragments, researchers can ask whether a shorter section:

  • retains a measurable response
  • loses endocrine activity
  • interacts differently with receptors
  • shows different metabolic stability

ACTH(4-7) Means Four Specific Residues

The notation ACTH(4-7) identifies residues 4, 5, 6, and 7 from ACTH:

Met-Glu-His-Phe

The numbering refers to positions in the native ACTH sequence rather than to Semax residue numbers generated independently.

Those Four Residues Become the N Terminus of Semax

In Semax they occupy positions:

  • Met1
  • Glu2
  • His3
  • Phe4

The ACTH-derived segment is therefore preserved exactly in sequence while its numbering changes in the isolated synthetic peptide.

The Design Does Not Retain ACTH Residues 8 Through 10

ACTH(4-10) contains:

Met-Glu-His-Phe-Arg-Trp-Gly

Semax contains:

Met-Glu-His-Phe-Pro-Gly-Pro

The difference begins immediately after Phe.

ACTH(4-10) and Semax Are Both Heptapeptides but Different Heptapeptides

They contain the same number of amino-acid residues.

However, three of their seven positions differ.

Matching length should not be mistaken for matching molecular identity.

Why ACTH Fragment Research Was Attractive

ACTH has both endocrine and central nervous system research history.

Older fragment studies suggested that some behavioral or neural observations could be investigated using ACTH-derived sequences shorter than the full hormone.

This encouraged design of analogues intended to separate molecular activities.

The Classical Hormonal Function of ACTH Was Not the Design Goal

Full ACTH is strongly associated with activation of the adrenal melanocortin 2 receptor and stimulation of adrenal steroidogenesis.

Semax research was developed around different experimental objectives.

The ACTH-derived sequence should therefore be viewed as a structural lineage rather than proof that Semax reproduces ACTH endocrine pharmacology.

The Melanocortin Core Helps Explain the Design Boundary

A key conserved melanocortin sequence is:

His-Phe-Arg-Trp

corresponding to ACTH residues 6 through 9.

Semax Preserves Only the First Half of HFRW

Semax contains:

His-Phe-Pro-Gly

across the analogous transition.

Arg-Trp is absent.

This substantial change prevents simplistic transfer of classical melanocortin-receptor pharmacology to Semax.

The PGP Tail Was Added as a Peptide-Design Element

The added sequence is:

Pro-Gly-Pro

PGP is a naturally occurring short peptide motif studied independently in biological systems.

Within Semax, however, it forms part of one continuous synthetic heptapeptide.

The Design Target Included Greater Metabolic Persistence

Short peptides are commonly susceptible to:

  • aminopeptidases
  • carboxypeptidases
  • endopeptidases

Published Semax research describes the PGP extension as increasing resistance to peptidase-mediated degradation.

C-Terminal Engineering Is a Common Peptide Strategy

Researchers can alter peptide stability through:

  • residue replacement
  • terminal modification
  • cyclization
  • addition of stabilizing sequences

Semax uses sequence extension rather than simply capping the C terminus chemically.

Why Proline Is Useful in Protease-Resistance Design

Proline has an unusual cyclic side chain bonded back to its backbone nitrogen.

This geometry can make peptide bonds near proline less compatible with some protease active sites.

The effect depends on the enzyme and neighboring sequence.

PGP Does Not Make Semax Permanently Stable

Biological systems still metabolize Semax.

Experiments have identified fragments derived from both the ACTH-related and PGP portions.

The design should therefore be described as altering degradation kinetics, not preventing degradation entirely.

The Extension Changes Molecular Mass

ACTH(4-7) and Semax differ by three residues.

Consequently, adding PGP changes:

  • molecular mass
  • terminal sequence
  • conformational possibilities
  • protease-recognition sites

The Extension Also Changes the C-Terminal Chemical Environment

ACTH(4-7) ends in phenylalanine.

Semax instead continues through PGP and terminates in proline.

This means carboxypeptidases encounter a different terminal residue.

Semax Is One Molecule, Not a Physical Mixture of Two Peptides

Writing ACTH(4-7) + PGP can help explain the historical design.

Chemically, however, Semax consists of seven covalently linked residues.

The peptide bond between Phe4 and Pro5 connects the two conceptual design regions.

The Phe-Pro Junction Is a New Structural Feature

That junction does not occur at the corresponding location in ACTH(4-10).

The new bond can influence:

  • backbone orientation
  • protease susceptibility
  • local conformation

Analog Design Changes More Than Stability

Replacing ACTH residues Arg-Trp-Gly with Pro-Gly-Pro potentially changes:

  • charge
  • aromatic character
  • hydrophobicity
  • receptor recognition
  • metabolite profile

The Arg-to-Pro Change Removes a Basic Side Chain

Arginine is commonly positively charged.

Proline is neutral.

This replacement changes local electrostatic properties.

The Trp-to-Gly Change Removes a Large Aromatic Side Chain

Tryptophan is bulky and aromatic.

Glycine has only hydrogen as its side chain.

This is a substantial steric and hydrophobic change.

The Final Gly-to-Pro Change Alters Backbone Constraint

Glycine is highly flexible.

Proline is comparatively conformationally restricted.

The terminal region of Semax therefore differs markedly from native ACTH(4-10).

Semax Should Not Be Described as Merely “Stabilized ACTH”

The phrase is too broad because Semax contains only four ACTH residues and replaces three others.

A more precise description is:

a synthetic ACTH(4-7)-PGP heptapeptide.

The Derivation Also Distinguishes Semax From ACTH(1-24)

ACTH(1-24) retains the entire N-terminal 24-residue region of ACTH and is pharmacologically much closer to the endocrine hormone.

Semax shares only residues 4 through 7.

ACTH(1-24) Evidence Is Not Semax Evidence

Studies involving ACTH(1-24) or full ACTH should not be used automatically to establish:

  • Semax pharmacokinetics
  • Semax receptor interactions
  • Semax endocrine effects
  • Semax clinical outcomes

ACTH(4-10) Evidence Also Needs Careful Separation

ACTH(4-10) is structurally closer to Semax than full ACTH, but its final three residues are different.

Experimental observations can provide design context without establishing equivalence.

Structure-Activity Research Depends on Such Comparisons

Useful comparator groups can include:

  • ACTH
  • ACTH(4-10)
  • ACTH(4-7)
  • Semax
  • PGP

Differences among these groups can help identify which structural region contributes to a measured effect.

PGP Alone Is an Especially Important Control

Because PGP is appended deliberately, studying PGP separately can help determine whether an observed Semax response:

  • requires the complete peptide
  • can be reproduced partly by PGP
  • depends primarily on the ACTH-derived region

Not Every Semax Finding Is Reproduced by PGP

Animal research comparing PGP with the complete peptide has reported different outcomes depending on the experimental endpoint.

This shows that PGP should not be considered a complete substitute for Semax.

The ACTH(4-7) Region Also Cannot Explain Every Finding Automatically

Even when a response appears associated with the ACTH-derived component, appending PGP can alter:

  • persistence
  • local exposure
  • degradation products
  • peptide conformation

The intact heptapeptide remains the actual experimental molecule.

Metabolites Add a Further Layer

After Semax degradation, fragments can arise from different parts of the molecule.

A biological response observed long after parent-peptide exposure could theoretically involve:

  • intact Semax
  • one or more metabolites
  • secondary cellular signalling

Distinguishing these possibilities requires pharmacokinetic and metabolite studies.

A Long-Lasting Response Does Not Prove Long-Lived Parent Peptide

A short-lived regulatory peptide can initiate signalling that persists after the parent molecule declines.

Duration of biological response and peptide half-life should therefore not be treated as the same measurement.

The ACTH(4-7) Sequence Deserves Its Own Structural Analysis

Met-Glu-His-Phe carries the exact ACTH-derived information retained in Semax.

The significance of those four positions is examined in What the ACTH(4-7) Sequence Means in Semax Research.

Reading a Semax Molecular-Design Source

The PubMed-indexed study Semax, an Analog of ACTH(4-10) With Cognitive Effects, Regulates BDNF and trkB Expression in the Rat Hippocampus identifies Semax as Met-Glu-His-Phe-Pro-Gly-Pro and places it explicitly within the ACTH(4-10) analogue research lineage.

The study's rat hippocampal gene-expression observations should remain preclinical molecular findings. The ACTH-derived design does not itself establish human cognitive effectiveness, general safety, or personal-use suitability.

Final Perspective

Semax was derived from ACTH fragment research by preserving residues 4 through 7, Met-Glu-His-Phe, and replacing the remaining ACTH(4-10) segment with Pro-Gly-Pro.

This design simultaneously changes the molecule's C-terminal sequence, charge distribution, aromatic content, conformation, degradation susceptibility, and possible receptor interactions. The PGP extension therefore represents more than a cosmetic addition to ACTH(4-7).

Semax should consequently be interpreted as a distinct synthetic heptapeptide created from ACTH-fragment structure-activity research, with evidence assigned to the final MEHFPGP molecule rather than transferred automatically from intact ACTH, ACTH(4-10), ACTH(4-7), or PGP.

Back to blog